about
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohortsPPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerThe cancer stem cell: evidence for its origin as an injured autoreactive T cellA longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal womenHemoglobin A1c concentrations and risk of colorectal cancer in women.Diabetes promotes DMH-induced colorectal cancer by increasing the activity of glycolytic enzymes in rats.Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.Panax ginseng: a role in cancer therapy?HDL cholesterol and cancer risk among patients with type 2 diabetes.Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality.Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients.Promoting Effects of Streptozotocin-induced Diabetes on Induction of Hepatic Preneoplastic Lesions by Diethylnitrosamine in RatsThe role of metformin in the management of NAFLDCancer-related fatigue syndrome.The insulin receptor: a new target for cancer therapy.Sirtuins: critical regulators at the crossroads between cancer and aging.Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) StudyHyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and ManagementDiabetes mellitus and risk of prostate cancer in the health professionals follow-up studyPPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.Dietary and metabolic control of stem cell function in physiology and cancer.Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients.Lipolytic actions of secretin in mouse adipocytes.G0/G1 switch gene-2 regulates human adipocyte lipolysis by affecting activity and localization of adipose triglyceride lipaseCHOP 5'UTR-c.279T>C and +nt30C>T variants are not associated with overweight condition or with tumors/cancer in Italians - a case-control study.Insulin glargine and cancer risk: an opinion statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy.Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men.Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors.History of allergies and autoimmune diseases and risk of brain tumors in adults.Induction of squamous cell carcinoma of forestomach in diabetic rats by single alloxan treatment.Reduced risk of prostate cancer among patients with diabetes mellitus.Cancer risk in patients with type 2 diabetes mellitus and their relatives.The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma.Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
P2860
Q21090132-E74528AC-856D-466F-9E79-43CF157B564BQ21328702-88D31A1E-F8BD-400F-B856-0771F491162EQ25256839-B68093EB-23F9-4B4C-A875-F8833B8577A9Q34236811-6D30A606-2B32-4A5D-BBD2-0B3F6576A435Q34314117-58F6F364-B330-4613-87E2-89F64274BA31Q34362225-7B38D081-7D49-4A63-8951-45C665DF59FBQ34391968-83D560CA-52A0-43D5-9329-A502CCC5B71DQ34536537-D67071D9-0326-4B6B-A93E-5AF471715F50Q34545361-755D4E5D-E368-4D9D-AD7B-7B702DD22449Q34656265-CC46836F-DDC3-4316-9B85-2CCDFB2595C2Q35135074-51D004C5-3A30-4C04-AAA2-22A8353C618DQ35603922-8857EB2F-BAF0-4F3B-840C-F64CFF935025Q35614956-699DF684-B662-4314-8EAF-7F43115D43A8Q35616864-CC68B755-30C5-4D82-B296-40AAA23DFED3Q35972002-E7075F88-826B-4F5F-B52B-6D721427D412Q36908428-27E02B80-DCE7-4A61-B95E-F55C2DFFF3FCQ36960888-A2E3BA05-9AF5-4837-92EC-632C97448CCDQ37091101-7B1FDDE6-5EAA-4941-8C05-6C4DD097CE95Q37187103-6B72819B-F772-437D-A25A-8914C9B5F829Q37656960-389B2ADD-92DE-4625-A532-3B7511794221Q37711151-D7C45FD4-0DE8-428D-89F7-E9922508E4D8Q38338775-979E05A4-5E1B-482E-B50B-A10D53E3252DQ40585475-C6C8323B-2C88-466F-83AD-60A644FFF381Q41862301-FCBD19D4-26AB-45E8-8E15-F0F48879840EQ42067305-825934EB-C619-44A8-9EFF-95C7A5E48D2FQ43092908-2D57814E-62CC-4EAB-B4CF-444A5CACABEDQ44027980-321296E9-8059-4F0B-99B3-D17C97636AB7Q44235240-837BBCF6-5ACD-43E7-B67F-F3A173917F9FQ47182422-22C421B3-67AA-4EB5-B3B5-5FDB7A5AA02CQ48620344-33546110-498C-4B23-AFB2-8C4547B3A9CDQ51790172-7DA891FC-6D4E-4FED-9753-05C1A58A942CQ52945076-A82CD4AA-8F9B-4783-B6EA-F902FD67A506Q53639960-F06F51A1-A4F7-40D5-B4BD-E0EE011DB709Q55139939-F5AA5A37-B3BF-4563-A6B7-283CAD351F67Q59265277-6DD05687-6636-4669-8DC8-14A417724B08
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The relation of type 2 diabetes and cancer.
@ast
The relation of type 2 diabetes and cancer.
@en
The relation of type 2 diabetes and cancer.
@nl
type
label
The relation of type 2 diabetes and cancer.
@ast
The relation of type 2 diabetes and cancer.
@en
The relation of type 2 diabetes and cancer.
@nl
prefLabel
The relation of type 2 diabetes and cancer.
@ast
The relation of type 2 diabetes and cancer.
@en
The relation of type 2 diabetes and cancer.
@nl
P2093
P1476
The relation of type 2 diabetes and cancer.
@en
P2093
Strickler HD
Wylie-Rosett J
P304
P356
10.1089/152091501300209633
P577
2001-01-01T00:00:00Z